Atracurium Besylate Injection, USP is indicated, as an adjunct to general anesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation.
From the U.S. FDA-approved label for Atracurium Besylate. Full label: DailyMed.
Atracurium Besylate Injection, USP is indicated, as an adjunct to general anesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation.
From the U.S. FDA-approved label for Atracurium Besylate. Full label: DailyMed.
Atracurium besylate should be administered intravenously. DO NOT GIVE ATRACURIUM BESYLATE BY INTRAMUSCULAR ADMINISTRATION. Intramuscular administration of atracurium besylate may result in tissue irritation and there are no clinical data to support this route of administration.
Directions from the U.S. FDA-approved label for Atracurium Besylate — your doctor or pharmacist may advise differently.
Atracurium besylate is contraindicated in patients known to have a hypersensitivity to it. Use of atracurium besylate from multiple dose vials containing benzyl alcohol as a preservative is contraindicated in patients with a known hypersensitivity to benzyl alcohol.
Excerpt from the U.S. FDA-approved label for Atracurium Besylate. Talk to a pharmacist or doctor before use.
ATRACURIUM SHOULD BE USED ONLY BY THOSE SKILLED IN AIRWAY MANAGEMENT AND RESPIRATORY SUPPORT. EQUIPMENT AND PERSONNEL MUST BE IMMEDIATELY AVAILABLE FOR ENDOTRACHEAL INTUBATION AND SUPPORT OF VENTILATION, INCLUDING ADMINISTRATION OF POSITIVE PRESSURE OXYGEN. ADEQUACY OF RESPIRATION MUST BE ASSURED THROUGH ASSISTED OR CONTROLLED VENTILATION. ANTICHOLINESTERASE REVERSAL AGENTS SHOULD BE IMMEDIATELY AVAILABLE. DO NOT GIVE ATRACURIUM BESYLATE BY INTRAMUSCULAR ADMINISTRATION. Atracurium has no known effect on consciousness, pain threshold, or cerebration. It should be used only with adequate anesthesia.
Warnings and precautions excerpt from the U.S. FDA-approved label for Atracurium Besylate — not a complete list. Talk to a pharmacist or doctor before use.
Observed in Controlled Clinical Studies Atracurium was well tolerated and produced few adverse reactions during extensive clinical trials. Most adverse reactions were suggestive of histamine release.
Excerpt from the U.S. FDA-approved label for Atracurium Besylate — not a complete list. Talk to a pharmacist or doctor about side effects.
३ ब्रान्ड · ३ निर्माता — NepalDoc सूचीमा — पूरै Atracurium Besylate गाइड हेर्नुहोस् →
Storage Atracurium Besylate Injection should be refrigerated at 2° to 8°C (36° to 46°F) to preserve potency. Storage conditions (25°C/77°F), use Atracurium Besylate Injection within 14 days even if re-refrigerated. Protect from light.
Storage information from the U.S. FDA-approved label for Atracurium Besylate.
Atcuron के हो?
Atcuron 10mg Injection भनेको Atracurium Besylate औषधि हो, Sun Pharmaceutical Industries Ltd. ले बनाएको। यो 10mg Injection रूपमा पाइन्छ।
Atcuron को सामान्य नाम के हो?
Atcuron को सामान्य नाम Atracurium Besylate हो।
नेपालमा Atracurium Besylate का कुन कुन ब्रान्ड उपलब्ध छन्?
NepalDoc सूचीमा Atracurium Besylate का ३ वटा ब्रान्ड छन्, ३ निर्माताबाट — जसमा Artacil 25mg Injection, Troycurium 10mg Injection पर्छन्।
Atcuron को मूल्य नेपालमा कति हो?
NepalDoc ले औषधिको मूल्य सूचीबद्ध गर्दैन। मूल्य हरेक फार्मेसीले आफैं तय गर्छ र समयसँगै परिवर्तन हुन्छ — यो पृष्ठले नेपालमा बिक्री हुने ब्रान्ड, यसको सामान्य नाम, निर्माता, शक्ति र प्याक विवरण पुष्टि गर्छ, ताकि तपाईं आफ्नो फार्मेसीमा मूल्य विश्वस्त भएर सोध्न सक्नुहोस्।
यो पृष्ठ सामान्य जानकारीका लागि मात्र हो, चिकित्सकीय सल्लाह होइन। औषधिको विवरण माथि उल्लेखित स्रोतहरूबाट आएको हो र परिवर्तन हुन सक्छ — प्रयोग गर्नुअघि डाक्टर वा फार्मासिस्टसँग औषधि, शक्ति र मात्रा पुष्टि गर्नुहोस्। सूचीमा हुनुले कुनै फार्मेसीमा औषधि उपलब्ध छ भन्ने ग्यारेन्टी दिँदैन।
नेपालडकका सबै खण्ड, एकै ठाउँमा।